Reimbursement for discarded drugs and biologicals (modifier JW)
This policy governs how UnitedHealthcare reimburses providers for discarded amounts of drugs and biologicals from single-use vials or packages when reported with modifier JW; it applies to UnitedHealthcare Commercial and Individual Exchange benefit plans and affects physicians, hospitals, and other providers/suppliers submitting CMS 1500 or UB04 claims.
No material clinical or coverage changes in this revision.
Reimbursement Criteria
Reimbursement criteria for discarded drugs/biologicals
Reimbursement is allowable when the discarded drug or biological originates from a single-use vial or single-use package, is reported with modifier JW on a separate claim line, and both administered and discarded amounts are documented in the medical record.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.